HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
16.07
+0.73 (4.76%)
Aug 13, 2025, 4:00 PM - Market closed
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HUTCHMED (China) stock has a target of 28, which predicts a 74.24% increase from the current stock price of 16.07.
Price Target: $28.00 (+74.24%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for HUTCHMED (China) is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $27 → $28 | Strong Buy | Maintains | $27 → $28 | +74.24% | Jul 22, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +18.23% | Aug 1, 2024 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $20 → $22 | Hold → Strong Buy | Upgrades | $20 → $22 | +37.52% | Nov 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +5.79% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +211.14% | Sep 5, 2023 |
Financial Forecast
Revenue This Year
724.74M
from 630.20M
Increased by 15.00%
Revenue Next Year
869.04M
from 724.74M
Increased by 19.91%
EPS This Year
0.47
from 0.04
Increased by 1,063.77%
EPS Next Year
0.13
from 0.47
Decreased by -71.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 841.0M | 1.0B | 1.3B | ||
| Avg | 724.7M | 869.0M | 1.0B | ||
| Low | 646.5M | 721.0M | 798.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 33.4% | 42.3% | 44.1% | ||
| Avg | 15.0% | 19.9% | 17.0% | ||
| Low | 2.6% | -0.5% | -8.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.71 | 0.23 | 0.39 |
| Avg | 0.47 | 0.13 | 0.21 |
| Low | 0.28 | -0.08 | 0.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1,677.2% | -50.2% | 195.6% |
| Avg | 1,063.8% | -71.5% | 57.1% |
| Low | 598.3% | - | -19.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.